Liu Xu-Chang, Liu Yu-Xiang, Liu Chun
The No. 1 Clinical Medical School, Shanxi Medical University, Taiyuan 030001, Shanxi Province, China.
Department of Nephrology, Shanxi Provincial People's Hospital, Taiyuan 030012, Shanxi Province, China.
World J Clin Cases. 2025 Apr 26;13(12):100248. doi: 10.12998/wjcc.v13.i12.100248.
This article discusses the coexistence of prostate adenocarcinoma and prostate urothelial carcinoma. Combining existing literature and research results, the potential mechanisms of the co-occurrence of these two cancers are explored, including the role of androgen receptor, gene mutations, and their complex interactions in cell signaling pathways, Also, the hypothesis of prostate cancer transformation into urothelial carcinoma is explained from some perspectives, including tumor multipotent stem cell differentiation, epithelial-mesenchymal transition, mesenchymal-epithelial transition, and other mechanisms. Ultimately, the goal is to provide more accurate diagnoses and more personalized treatments in clinical practice, as well as to lay the foundation for improving patient prognoses in the future.
本文讨论了前列腺腺癌和前列腺尿路上皮癌的共存情况。结合现有文献和研究结果,探讨了这两种癌症同时发生的潜在机制,包括雄激素受体的作用、基因突变及其在细胞信号通路中的复杂相互作用。此外,还从肿瘤多能干细胞分化、上皮-间质转化、间质-上皮转化等机制的一些角度解释了前列腺癌转化为尿路上皮癌的假说。最终目标是在临床实践中提供更准确的诊断和更个性化的治疗,并为未来改善患者预后奠定基础。